NCT01285466View on ClinicalTrials.gov

A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Metastatic or Locally Advanced Solid Tumors
Interventions
DRUG

BEZ235 + paclitaxel

DRUG

BKM120 + paclitaxel

DRUG

BEZ235 + paclitaxel + trastuzumab

DRUG

BKM120 + paclitaxel + trastuzumab

Trial Locations (10)

1000

Novartis Investigative Site, Brussels

1200

Novartis Investigative Site, Brussels

2610

Novartis Investigative Site, Wilrijk

7000

Novartis Investigative Site, Chur

9007

Novartis Investigative Site, Sankt Gallen

41013

Novartis Investigative Site, Seville

45147

Novartis Investigative Site, Essen

50937

Novartis Investigative Site, Cologne

1066 CX

Novartis Investigative Site, Amsterdam

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY